GB202111288D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB202111288D0
GB202111288D0 GBGB2111288.3A GB202111288A GB202111288D0 GB 202111288 D0 GB202111288 D0 GB 202111288D0 GB 202111288 A GB202111288 A GB 202111288A GB 202111288 D0 GB202111288 D0 GB 202111288D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2111288.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jaz Innovation Ltd
Original Assignee
Jaz Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaz Innovation Ltd filed Critical Jaz Innovation Ltd
Priority to GBGB2111288.3A priority Critical patent/GB202111288D0/en
Publication of GB202111288D0 publication Critical patent/GB202111288D0/en
Priority to PCT/EP2022/071877 priority patent/WO2023012244A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
GBGB2111288.3A 2021-08-04 2021-08-04 Combination therapy Ceased GB202111288D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2111288.3A GB202111288D0 (en) 2021-08-04 2021-08-04 Combination therapy
PCT/EP2022/071877 WO2023012244A1 (en) 2021-08-04 2022-08-03 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2111288.3A GB202111288D0 (en) 2021-08-04 2021-08-04 Combination therapy

Publications (1)

Publication Number Publication Date
GB202111288D0 true GB202111288D0 (en) 2021-09-15

Family

ID=77651280

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2111288.3A Ceased GB202111288D0 (en) 2021-08-04 2021-08-04 Combination therapy

Country Status (2)

Country Link
GB (1) GB202111288D0 (en)
WO (1) WO2023012244A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116270657B (en) * 2023-05-18 2023-08-18 智泽童康(广州)生物科技有限公司 Pharmaceutical composition for preventing and/or treating gastrointestinal diseases and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920008160B1 (en) * 1990-06-01 1992-09-24 윤택구 Anticarcinogenic composition
CN101478981A (en) * 2006-06-27 2009-07-08 兴和株式会社 Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue
TW200824676A (en) * 2006-10-24 2008-06-16 Kowa Co Cardiovascular drug
US11077123B2 (en) * 2016-02-29 2021-08-03 Tel Hashomer Medical Research Infrastructure And Services Ltd. Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer
KR102093872B1 (en) * 2017-07-03 2020-03-27 진호성 Injection Composition For Fat Reduction and method of manufacturing the same
EP3986420A1 (en) * 2019-06-18 2022-04-27 Mitopower LLC Nicotinyl riboside compounds and their uses

Also Published As

Publication number Publication date
WO2023012244A1 (en) 2023-02-09

Similar Documents

Publication Publication Date Title
GB202111288D0 (en) Combination therapy
GB202108303D0 (en) Therapy
GB202004189D0 (en) Combination therapy
IL304223A (en) Combination therapy
GB202109377D0 (en) Combination therapy
GB202109375D0 (en) Combination therapy
GB202109373D0 (en) Combination therapy
GB202107824D0 (en) Combination therapy
GB202107706D0 (en) Combination therapy
GB202107709D0 (en) Combination therapy
GB202107713D0 (en) Combination therapy
GB202104037D0 (en) Combination therapy
GB202015916D0 (en) Combination therapy
GB202012161D0 (en) Combination therapy
GB202009178D0 (en) Combination therapy
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202015780D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)